Skip to main content
. 2023 Jan 26;12(2):193. doi: 10.3390/biology12020193

Figure 1.

Figure 1

Concentrations of aluminum in the brain, kidney, liver, small intestine, large intestine, serum, blood and femur after the three-month oral administration of silicates. C denotes the control group; T denotes the experimental group receiving tribomechanically activated zeolite clinoptilolite (TMAZ); P denotes the experimental group receiving the double tribomechanically activated zeolite clinoptilolite (PMA zeolite); and L denotes the experimental group receiving Ludox silica. Asterisk (*) denotes significant differences between the experimental groups, with control at p < 0.05.